newsfilter
← Latest News
GlobeNewswire·

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

DENVER, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the "Company"), a biopharmaceutical company focused on the treatment of mental health and addiction, today announced that it has file